Neudle.com: risk factors for multiple sclerosis

Differential
(Click to cross reference)

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

activities of daily living

activities of daily living scale

adalimumab

advances in neurology

adverse drug reaction

amyotrophic lateral sclerosis

analgesic

angiography, cerebral

anosmia

anterior horn cell disease

anti JC virus antibodies

antibiotic prophylaxis

antibiotics

anticoagulant, contraindications

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants, effectiveness

anticonvulsants, selection of

antiviral agents

Apgar score

arrhythmia, cardiac

arteriovenous malformation, cerebral

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection

bacterial infection, CNS

Barkhof MR criteria for MS

behavior modification

blood dyscrasias, neurologic findings with

bone marrow biopsy

bone scanning

bone survey

Borrelia burgdorferi infection

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

Call-Fleming syndrome

cancer, cerebrovascular accident complicating patients with

candida albicans

cannabinoids

carcinoma

cardiovascular disease

central nervous system, infection of

central vein sign

cerebral arteries

cerebral edema

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral palsy

cerebral palsy, risk factors

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, proteincytologic dissociation

cerebrovascular accident

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, classification

cerebrovascular accident, etiology

cerebrovascular accident, incidence of

cerebrovascular accident, neonatal

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular disease, risk factors in

channelopathy

chemotherapy, CNS treatment and complications with

child abuse

children

chiropractic manipulation

concentration, impaired

confusion

congenital heart disease, CNS complications with

congestive heart failure

controversies in neurology

corpus callosum, lesion of

cranial nerve palsies

creatine phosphokinase(CPK)elevated

critical care unit

critical illness

cytomegalovirus infection

daclizumab

dehydration

delay in diagnosis

delayed muscle relaxation

delivery, complicated

demyelinating disease

dermatomyositis

developmental disability

developmental evaluation

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

dizziness

drug abuse

drug holiday

drug induced neurologic disorders

drug withdrawal

dural arteriovenous malformation

dural sinus thrombosis

dyskinesia

efficacy

electrical injury of nervous system

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, interictal

electromyogram

emergencies, neurologic

encephalitis

encephalitis, autoimmune

epidemiology of neurology

epilepsy

episodic disorders

Epstein-Barr virus

Epstein-Barr virus, negative

ergotamine

etanercept

Europe

evidence-based research

exercise

eye movement, painful

fibrinolytic agents, complications

fine motor function, impaired

gammaglobulin therapy, intravenous

gender

gene

gene mutation

genetic neurologic disorders

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, etiology of

head injury

head injury, pediatric

headache

headache, recurrent

headache, severe

headache, thunderclap

hearing loss

heat intolerance

heatstroke

heparin, low-molecular-weight

hepatic failure

hepatitis B vaccine

heralding manifestation

herniated disc

herniated disc, lumbar

herniated disc, lumbar-conservative vs.surgical treat.of

herniated disc, lumbar-laminectomy

herpes simplex encephalitis

herpes virus

herpes virus infection

herpes zoster

HLA

hormone replacement

hospital length of stay

hot bath test

human T-lymphotropic virus type I(HTLV-I)

hydrocephalus

hypereosinophilic syndrome(HES)

hyperglycemia

hypersensitivity reaction

hypertension

hyperthermia

hypertrophic intracranial pachymeningitis

hypotension, systemic

hypoxia

hypoxia, newborn

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

imbalance

imbalance, postural

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunization, neurologic complications with

immunofluorescence

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

incidence

inebilizumab

infection

infectious mononucleosis

infliximab

intellectual deficit

intelligence quotient

intelligence testing in children

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial hemorrhage

intrauterine

JC virus

Kappa light chain biomarkers

learning disability, in children

leg spasms

leg spasms, painful

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

low back pain

low birth weight

lumbar puncture

lumbar puncture, indications for

lumbar spine manipulation

Lyme disease

lymphadenopathy

lymphoma

lymphoma, primary of CNS

malformation, vascular

malformation, vascular, cerebral

malignancy screen

malpractice

marihuana

McDonald criteria for MS

medical-legal aspects of neurology

medication withdrawal

memory, impairment of

meningitis

meningitis, adults

meningitis, aseptic

meningitis, bacterial

meningitis, bacteriologic etiology of

meningitis, children

meningitis, clinical features of

meningitis, CSF cell count-normal

meningitis, CSF findings in

meningitis, factors influencing mortality in

meningitis, iatrogenic

meningitis, late neurologic sequelae in

meningitis, meningococcal

meningitis, neurologic aspects and complications of

meningitis, pneumococcal

meningitis, prophylaxis against

meningitis, spinal fluid smear and culture of

meningitis, treatment of

meningitis, treatment of, empirical

meningoencephalitis

menses

mental status, abnormal

mesial temporal sclerosis

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

molecular genetics

monoclonal antibodies

monoclonal gammopathy

movement disorder, psychogenic

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, incidental finding

MRI, lesion burden

MRI, magnetization transfer sequence

multiple sclerosis, aggressive

multiple sclerosis, children

multiple sclerosis, clinical patterns

multiple sclerosis, conjugal

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, lesion location

multiple sclerosis, linoleic acid in

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, etiology of

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, transverse

myelitis, transverse, prognosis

myelopathy, transverse

myocarditis

myopathy

myopathy, critically ill

myotonia

nabiximols

natalizumab

natalizumab, discontinuation

negative

neisseria meningitis

neoplasm, primary of CNS

neoplasm, primary of CNS-children

nerve conduction studies

nerve growth factor

neuroendocrinology

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neurologic signs

neurologic symptoms

neurological intensive care

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, painful

neuropathy, peripheral, treatment

neuroprotective agents

neurotoxic

newborn, evaluation of

nocardiosis

nonsteroidal anti-inflammatory drug

ocrelizumab

ofatumumab

old age, neurology of

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

oral contraceptives

oral contraceptives, neurologic complications with

organomegaly

pachymeningitis, cranial

paramagnetic rim lesion, MR

paramyotonia congenita

Parkinson disease

pathologic reflex

patient information and support

percussion induced muscle contraction

Persistent postural-perceptual dizziness

personality change

pertussis immunization

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

pneumonia

POEMS syndrome

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, critically ill

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

premarin

premature infant

premature infant, problems in

prenatal

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

psychological testing

psychological testing, children

rehabilitation for neurologic disorders

renal failure

respiratory tract infection

retinal hemorrhages

retinal lesion

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

risk factors

risk stratification

risk-benefit assessment

seizure, age of onset

seizure, complications following

seizure, diagnosis of

seizure, drug resistance

seizure, etiology of

seizure, febrile

seizure, focal

seizure, immunization causing

seizure, incidence of

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, neonatal

seizure, prognosis in childhood

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, polytherapy

seizure, treatment, adjunctive therapy

selective serotonin reuptake inhibitors

sensorineural hearing loss

serotonin norepinephrine reuptake inhibitors

shared decision making

sinusitis

skin, lesions in neurologic disorders

small vessel disease

sodium channel dysfunction

spasticity

spasticity, treatment of

spinal cord

spinal cord, lesion of

spinal manipulation

spirochete infection

status epilepticus

status epilepticus, nonconvulsive

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stress, emotional

stroke, progression of

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

subdural hematoma

subdural hematoma, neonates and infants

sun exposure

superior sagittal sinus thrombosis

systemic illness

T cell lymphocytes

temporal lobe, lesion

temporal lobe, lesion, bilateral

tick-borne encephalitis

tissue plasminogen activator, intravenous

toxoplasma gondii

transient ischemic attack

transient neurologic deficit

trauma

travel, foreign

treatment of neurologic disorder

trigeminovascular system

triptans

tumor necrosis factor

tumor necrosis factor inhibitor

twins

Uhthoff's syndrome

ultraviolet light

urinary tract infection

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

vascular malformation, children, intracranial

vasoconstrictive drugs

vision, failure of in childhood

visual field defect

visual loss

vitamin D

vitamin supplementation

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

Showing articles 450 to 500 of 9967 << Previous Next >>

Responding to Medical Events During Commercial Airline Flights
NEJM 346:1067-1073, Gendreau,M.A. &DeJohn,C., 2002

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002

Emergent Use of Anticoagulation for Treatment of Patients with Ischemic Stroke
Stroke 33:856-861, Adams,H.P., 2002

Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002

Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002

Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002

Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002

Atrial Fibrillation and Stroke
Stroke 32:803-808, Hart,R.G. &Halperin,J.L., 2001

Vaccinations and the Risk of Relapse in Multiple Sclerosis
NEJM 344:319-326,372, Confavreux,C.,et al, 2001

Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001

Recurrent Brain Hemorrhage is More Frequent Than Ischemic Stroke After Intracranial Hemorrhage
Neurol 56:773-777, Bailey,R.D.,et al, 2001

Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001

Multiple Simultaneous Intracerebral Hemorrhages
Arch Neurol 58:629-632, Maurino,J.,et al, 2001

Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis
Neurol 56:1416, Yoshida,E.M.,et al, 2001

Chickenpox and Stroke in Childhood
Stroke 32:1257-1262, Askalan,R.,et al, 2001

Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001

Randomised Trial of a Perindopril-based Blood-pressure-lowering Regimen Among 6105 Individuals with Previous Stroke or Transient Ischaemic Attack
Lancet 358:1033-1041,1026, PROGRESS Collaborative Group, 2001

Coexisting Causes of Ischemic Stroke
Arch Neurol 57:1139-1144,1113, Moncayo,J. et al, 2000

Recommendations for the Management of Patients with Unruptured Intracranial Aneurysms
Stroke 31:2742-2750, Bederson,J.B.,et al, 2000

Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000

The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000

Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000

Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000

Ischemic Stroke in Young Women: Risk of Recurrence During Subsequent Pregnancies
Neurol 55:269-274, Lamy,C. et al, 2000

Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
NEJM 342:240-245,276, O'Donnell,H.C.,et al, 2000

Multiple Acute Stroke Syndrome, Marker of Embolic Disease?
Neurol 54:674-678, Baird,A.E.,et al, 2000

Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Neural-Tube Defects
NEJM 341:1509-1519,1485, Botto,L.D.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Intracerebral Hemorrhage in Young People,Analysis of Risk Factors,Location,Causes,and Prognosis
Stroke 30:537-541, Rutz-Sandoval,J.L.,et al, 1999

Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Multiple Cerebral Infarctions Associated with Ovarian Hyperstimulation Syndrome
Neurol 53:225-227, Yoshii,F.,et al, 1999

Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Extended Use of Glatiramer Acetate (Copaxone) Is Well Tol & Maint Its Clin Effect on MS Relapse Rate & Degree of Disabil
Neurol 50:701-708, Johnson,K.P.,et al, 1998

Survival and Recurrence After First Cerebral Infarction, Study in Rochester, Minn, 1975-1989
Neurol 50:208-216, Petty,G.W.,et al, 1998

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

Risk of Amyotrophic Lateral Sclerosis & History of Physical Activity, A Population Study
Arch Neurol 55:201-206, Longstreth,W.T.,et al, 1998

Neurologic Outcomes in Children with Post-Pump Choreoathetosis
J Pediatr 132:162-164, Holden,K.R.,et al, 1998

Interferon Treatment for Multiple Sclerosis:Autoimmune Complications May be Lethal
Neurol 50:570-571, Durelli,L.,et al, 1998

Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998

Showing articles 450 to 500 of 9967 << Previous Next >>